- Home
- SOLV
SOLV
SOLVENTUM CORP
as 07-26-2024 4:00pm EST
Stocks
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
| Founded: | 2023 | Country: | United States |
| Employees: | N/A | City: | ST. PAUL |
| Market Cap: | 9.3B | IPO Year: | N/A |
| Target Price: | $58.00 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $47.16 - $72.40 | Next Earning Date: | 08-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 0.83% | Revenue Growth (next year): | 0.24% |
Latest SOLVENTUM CORP News
SOLV Breaking Stock News: Dive into SOLV Ticker-Specific Updates for Smart Investing
The Wall Street Journal
3 days ago
Stocks to Watch Tuesday: Spotify, NXP, GM, Alphabet, UPS
Simply Wall St.
3 days ago
Solventum Corporation (NYSE:SOLV) Shares Could Be 26% Below Their Intrinsic Value Estimate
PR Newswire
11 days ago
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
PR Newswire
24 days ago
U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
Simply Wall St.
a month ago
Should You Be Excited About Solventum Corporation's (NYSE:SOLV) 33% Return On Equity?
PR Newswire
a month ago
Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue
Argus Research
a month ago
Analyst Report: Solventum Corp
Argus Research
a month ago
Market Digest: JBL, MCK, ES, HPE, SOLV
Compare SOLV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOLV SOLVENTUM CORP - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.